Innoviva Inc (INVA) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Innoviva Inc has achieved a revenue compound annual growth rate (CAGR) of 1.6%, while earnings have grown at -46.9% CAGR.
Historical revenue and profitability trends for Innoviva Inc
The chart above illustrates Innoviva Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Innoviva Inc's business.
How efficiently Innoviva Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Innoviva Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Innoviva Inc to continue growing earnings in the coming year. The consensus analyst rating is 4 based on 1 analyst.
Based on our comprehensive analysis, Innoviva Inc (INVA) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Innoviva Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Innoviva Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: INVA Valuation, INVA Dividend, INVA Financial Health
Compare: INVA vs AAPL, INVA vs MSFT, INVA vs GOOGL